Tepecik Education and Research Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01917396
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

İzmi̇r Tepeci̇k Eği̇ti̇m Ve Arştırma Hastanesi̇ | Tepecik Research and Training Hospital | Tepecik Training and Research Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

rabeprazole (pariet) (1 trial)

Drugs in Phase 3 Trials (3)

azithromycin (zithromax) (1 trial)

favipiravir (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

Drugs in Other Trials (1)

sodium phosphate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gastroesophageal Reflux (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5